Press Releases

2012

First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial
Seattle, WA | February 22, 2012

IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial
Seattle, WA | January 31, 2012

IDRI Awarded Additional Funds for Novel TB Drugs
Seattle, WA | January 11, 2012

2011

Human trials initiated for new HIV vaccine
Seattle, WA | December 21, 2011

IDRI Announces New VP Tuberculosis Drug Development: Gail H. Cassell, PhD, to Join IDRI
Seattle, WA | December 7, 2011

IDRI to Present at India - US Forum: Dr. Christopher Fox to Discuss IDRI's Technology Transfer Efforts
Seattle, WA | November 29, 2011

Eli Lilly and Company Provides IDRI with Additional Funding for Identification of New Tuberculosis Therapies
Seattle, WA | November 17, 2011

IDRI Partners with Global Research Initiative ADITEC to Accelerate Human Vaccine Development
Seattle, WA | October 17, 2011

The Paul G. Allen Family Foundation Supports Launch of IDRI's TB Vaccine Clinical Program
Seattle, WA | October 12, 2011

GlaxoSmithKline Donates Scientific Equpment to Advance IDRI's Global Health Mission
Seattle, WA | October 3, 2011

IDRI Launches New and Improved Website
Seattle, WA | September 7, 2011

IDRI, USAID Strike New Collaboration for Malaria Vaccine Development
Seattle, WA | August 16, 2011

IDRI Announces New EVP Business Development & External Affairs
Seattle, WA | August 2, 2011

IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer
Seattle, WA | February 15, 2011

IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs
Seattle, WA | January 14, 2011

IDRI Receives DARPA Grant to Develop a Novel Vaccine to Combat Pandemic Flu
Seattle,WA | January 7, 2011

2010

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza
Seattle, WA | December 3, 2010

IDRI Awarded $790,200 Grant from US Government to Develop Pandemic Flu Vaccine With Cantacuzino Institute
Seattle, WA | December 3, 2010

IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
Seattle, WA | October 14, 2010


IDRI and Merial Enter into Research Collaboration
Seattle, WA | Duluth, GA | July 14, 2010

2009

The Lilly TB Drug Discovery Initiative Announces New Collaborator
Seattle, September 29, 2009

IDRI Initiates Therapeutic Vaccine Clinical Trial in Sudan Against Leishmaniasis
Seattle, WA | Aug 27, 2009

IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
Seattle, WA | Nes Ziona, Israel | August 31, 2009

IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program
Seattle | June 25, 2009

IDRI Makes its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
Seattle, WA | June 11, 2009

Global Health Research to Push for More U.S. Support: Dr. Steve Reed has been named Global Health Research Ambassador
Seattle, WA | January 14, 2009

2008

IDRI Awarded $7 Million Grant from the Bill & Melinda Gates Foundation to Fight Visceral Leishmaniasis in Africa
Seattle, WA | December 18, 2008

IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
Seattle, WA | November 20, 2008

IDRI Receives NIH Funding to Design Adjuvants to Improve New TB Vaccine Protection
Seattle, WA | August 26, 2008

3M Collaborates with Infectious Disease Research Institute on Vaccine Adjuvants
St. Paul, MN | May 1, 2008

New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
Seattle, WA | January 30, 2008

2007

Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
Seattle, WA | December 4, 2007

Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
Seattle, WA | October 19, 2007

Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
Seattle, WA | May 31, 2007